Recombinant human erythropoietin mutants and therapeutic methods employing them
US5614184A · kind A · utility
138Cited by
6References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 1995 |
| Grant date | Mar 25, 1997 |
| Priority date | — |
| Expiry date | Feb 2, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
DNA encoding modified, secretable erythropoietin proteins whose ability to regulate the growth and differentiation of red blood cell progenitors are different from the wildtype recombinant erythropoietin and to methods of modifying or altering the regulating activity of a secretable erythropoietin and using modified secretable erythropoietin proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.